Our goal is to conduct 100 clinical trials of (genetic) preventive therapies in 10 years by making use of the regulatory flexibility of Próspera ZEDE. Right now, we are busy launching our first batch of trials targeting age-related hair loss, skin quality deterioration, and sarcopenia via repurposing an existing safe and effective genetic therapy.